PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

Completed · Phase 1 · Has a placebo group

Conditions studied: Parkinson Disease

In brief

The purpose of this study is to test the safety and tolerability of the investigational drug PF-06412562 compared to the current medical standard of care medication for Parkinson's disease, carbidopa/levodopa. This research also is being done to find out if the investigational drug PF-06412562 can help improve the motor (movement) function, alertness, and cognitive (thinking) skills of people who are considered to be in the advanced-stage of Parkinson's disease. In this study, PF06412562 is 'investigational,' which means that it is experimental and has not been approved by the US Food and Drug Administration (FDA), but can be used in clinical research studies such as this one.

Key facts

Study ID
NCT03665454
Run by
Milton S. Hershey Medical Center
People needed
8
Starts
2018-09-24
Expected to finish
2019-04-21
Last updated by the study team
2019-07-31

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.